Sanusi, K. O., Asiwe, J. N., Okonofua, D. E., Adagbada, E. O., Alawode, D. I., Ayinde, T. O., & Fasanmade, A. A. (2026). Haematological and electrocardiographic safety of adrenergic antagonists and glibenclamide co-administration in streptozotocin-induced diabetic Wistar rats. Comparative Clinical Pathology, 35(1), 1. https://doi.org/10.1007/s00580-026-03854-3
Chicago Style (17th ed.) CitationSanusi, Kamaldeen Olalekan, Jerome Ndudi Asiwe, David Ehikhuemen Okonofua, Ebunoluwa Oluwabusola Adagbada, Damilola Ifeoluwa Alawode, Taofeek Olanrewaju Ayinde, and Adesoji Adedipe Fasanmade. "Haematological and Electrocardiographic Safety of Adrenergic Antagonists and Glibenclamide Co-administration in Streptozotocin-induced Diabetic Wistar Rats." Comparative Clinical Pathology 35, no. 1 (2026): 1. https://doi.org/10.1007/s00580-026-03854-3.
MLA (9th ed.) CitationSanusi, Kamaldeen Olalekan, et al. "Haematological and Electrocardiographic Safety of Adrenergic Antagonists and Glibenclamide Co-administration in Streptozotocin-induced Diabetic Wistar Rats." Comparative Clinical Pathology, vol. 35, no. 1, 2026, p. 1, https://doi.org/10.1007/s00580-026-03854-3.